Trade Summary

2 days ago, Seshadri Vishwas, serving as CEO at Abeona Therapeutics Inc. (ABEO), sold 25,000 shares at $5.31 per share, for a total transaction value of $132,740.00. Following this transaction, Seshadri Vishwas now holds 1,164,818 shares of ABEO.

This sale represents a 2.00% decrease in Seshadri Vishwas's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, December 29, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 29, 2025, meaning the disclosure happened on the same day as the trade.

Abeona Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.